{"entity":{"type":"insider","cik":"0001666380","url":"/insider/0001666380","json_url":"/insider/0001666380.json","name":"Rosenberg Ellen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":12,"first":"2016-06-06","last":"2025-11-26","span_basis":"filed_date"},"name_variants":[{"name":"Rosenberg Ellen","source":"filing","n_filings":12,"first_seen":"2016-06-06","last_seen":"2025-11-26"}],"transactions":[{"id":4755434,"accession":"0001193125-25-301017","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-301017","line_url":"/filing/0001193125-25-301017#line-7","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23621.0,"shares_display":"23,621","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":236210.0,"total_display":"236,210.00","total_whole":"236,210","shares_owned_after":507710.0,"shares_owned_after_display":"507,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-11-26","scope":"insider"},{"id":4755428,"accession":"0001193125-25-301017","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-301017","line_url":"/filing/0001193125-25-301017#line-5","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":360000.0,"total_display":"360,000.00","total_whole":"360,000","shares_owned_after":507710.0,"shares_owned_after_display":"507,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4755418,"accession":"0001193125-25-301017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-301017","line_url":"/filing/0001193125-25-301017#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":10.063,"price_display":"10.06","price_state":"stated","total_value":362268.0,"total_display":"362,268.00","total_whole":"362,268","shares_owned_after":507710.0,"shares_owned_after_display":"507,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":2414889,"accession":"0000950170-24-012843","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-012843","line_url":"/filing/0000950170-24-012843#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29600.0,"shares_display":"29,600","price_per_share":13.0006,"price_display":"13.00","price_state":"stated","total_value":384817.76,"total_display":"384,817.76","total_whole":"384,818","shares_owned_after":367654.0,"shares_owned_after_display":"367,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":2414872,"accession":"0000950170-24-012843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-012843","line_url":"/filing/0000950170-24-012843#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5200.0,"total_display":"5,200.00","total_whole":"5,200","shares_owned_after":367654.0,"shares_owned_after_display":"367,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2512379,"accession":"0000950170-24-002111","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-002111","line_url":"/filing/0000950170-24-002111#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":14.2073,"price_display":"14.21","price_state":"stated","total_value":426219.0,"total_display":"426,219.00","total_whole":"426,219","shares_owned_after":342285.0,"shares_owned_after_display":"342,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-04","scope":"insider"},{"id":7963578,"accession":"0000950170-23-073627","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-073627","line_url":"/filing/0000950170-23-073627#line-4","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.0654,"price_display":"14.07","price_state":"stated","total_value":70327.0,"total_display":"70,327.00","total_whole":"70,327","shares_owned_after":342285.0,"shares_owned_after_display":"342,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-28","scope":"insider"},{"id":7963572,"accession":"0000950170-23-073627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-073627","line_url":"/filing/0000950170-23-073627#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":14.0028,"price_display":"14.00","price_state":"stated","total_value":420084.0,"total_display":"420,084.00","total_whole":"420,084","shares_owned_after":342285.0,"shares_owned_after_display":"342,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":8151103,"accession":"0001209191-23-004863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004863","line_url":"/filing/0001209191-23-004863#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31839.0,"shares_display":"31,839","price_per_share":13.3172,"price_display":"13.32","price_state":"stated","total_value":424006.3308,"total_display":"424,006.33","total_whole":"424,006","shares_owned_after":332345.0,"shares_owned_after_display":"332,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider"},{"id":6612937,"accession":"0001209191-22-044345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044345","line_url":"/filing/0001209191-22-044345#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11123.0,"shares_display":"11,123","price_per_share":10.0218,"price_display":"10.02","price_state":"stated","total_value":111472.4814,"total_display":"111,472.48","total_whole":"111,472","shares_owned_after":280707.0,"shares_owned_after_display":"280,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6630977,"accession":"0001209191-22-038763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038763","line_url":"/filing/0001209191-22-038763#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11122.0,"shares_display":"11,122","price_per_share":10.0047,"price_display":"10.00","price_state":"stated","total_value":111272.2734,"total_display":"111,272.27","total_whole":"111,272","shares_owned_after":291830.0,"shares_owned_after_display":"291,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-22","scope":"insider"},{"id":6652798,"accession":"0001209191-22-023909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023909","line_url":"/filing/0001209191-22-023909#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11018.0,"shares_display":"11,018","price_per_share":9.0576,"price_display":"9.06","price_state":"stated","total_value":99796.6368,"total_display":"99,796.64","total_whole":"99,797","shares_owned_after":302952.0,"shares_owned_after_display":"302,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider"},{"id":2292503,"accession":"0001209191-20-043064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043064","line_url":"/filing/0001209191-20-043064#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.2637,"price_display":"15.26","price_state":"stated","total_value":457911.0,"total_display":"457,911.00","total_whole":"457,911","shares_owned_after":195169.0,"shares_owned_after_display":"195,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-16","filed_date":"2020-07-20","scope":"insider"},{"id":3086258,"accession":"0001209191-20-004128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-004128","line_url":"/filing/0001209191-20-004128#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22100.0,"shares_display":"22,100","price_per_share":10.3458,"price_display":"10.35","price_state":"stated","total_value":228642.18,"total_display":"228,642.18","total_whole":"228,642","shares_owned_after":185350.0,"shares_owned_after_display":"185,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-17","scope":"insider"},{"id":2266843,"accession":"0001209191-20-001227","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-001227","line_url":"/filing/0001209191-20-001227#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10448.0,"shares_display":"10,448","price_per_share":9.5601,"price_display":"9.56","price_state":"stated","total_value":99883.9248,"total_display":"99,883.92","total_whole":"99,884","shares_owned_after":201332.0,"shares_owned_after_display":"201,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":2924820,"accession":"0001209191-16-125984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-125984","line_url":"/filing/0001209191-16-125984#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001666380","owner_name":"Rosenberg Ellen","owner_display_name":"Rosenberg Ellen","owner_url":"/insider/0001666380","role":"Officer (General Counsel & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Secy","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":7.67,"price_display":"7.67","price_state":"stated","total_value":115050.0,"total_display":"115,050.00","total_whole":"115,050","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Officer (Chief Legal Officer)","n_filings":12,"first_seen":"2016-06-06","last_seen":"2025-11-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001666380","retrieved_at":"2026-08-25T10:42:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}